JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'mgcd 265'

Search results for: 'mgcd 265'

A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL
A8313 RAF265

Target: Raf|VEGFR

Summary: Multiple intracellular kinases inhibitor

≥25.9 mg/mL
A8385 BMS265246

Target: Cyclin-Dependent Kinases

Summary: CDK1/2 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥17.25 mg/mL
A8566 GSK744 (S/GSK1265744)

Summary: HIV integrase inhibitor, oral active and long-acting

insoluble in H2O; insoluble in EtOH; ≥19.35 mg/mL
B2175 GSK2656157
2 Citation

Summary: PERK inhibitor
B5333 SB 265610

Summary: CXCR2 antagonist, potent

Soluble in DMSO
C4181 ML-265

Summary: tumor-specific PKM2 activator

≥37.3 mg/mL
A3253 BMS-626529
2 Citation

Target: HIV-1 gp120

Summary: HIV-1 attachment inhibitor

insoluble in H2O; insoluble in EtOH; ≥1.48 mg/mL
A4089 Mocetinostat (MGCD0103, MG0103)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,isotype-selective and potent

insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
BA2064 DSM265

Summary: DSM265 is a long-acting Plasmodium falciparum dihydroorotic acid dehydrogenase inhibitor.